The revised S-1 filing demonstrates the risk of shorter deals that weaken Anthropic’s quarterly numbers. This quarter may not be the last.
3 minute read
The Midterms
Why a Contested Election Won’t Derail the Market
History suggests investors would look past an indecisive electoral result or one that comes under White House scrutiny.
Today's Other Headlines
Barron's Newsletters
Investor Circle
Yes, Alphabet Stock Got Slammed. No, We’re Not Selling.
The Google-parent trades at a rare discount. If it simply returns to its historical valuation relative to Apple, the stock has nearly 50% upside.
4 minute read
Idexx Is Today’s Best S&P 500 Stock. It’s Defying an Industry Slump.
Idexx Laboratories reported strong growth in veterinary diagnostics, offsetting sluggish industry demand.
1 minute read
Election Ads and the World Cup Fuel Fox Earnings Beat. There’s More Where That Came From.
Fox Corp.’s advertising revenue surges, driven by the FIFA World Cup, an active election cycle, and strong growth from Tubi.
2 minute read
November 2, 2026
Inside China’s Ruthless EV Blitz Upending the World
China is flooding the world with cars, hurting rivals everywhere. Why GM and Lear could thrive anyway.
Long Read
Sorry, Trump. More Russian Oil Won’t Take Down Energy Prices. Here’s What Will.
Trump needs to do more than welcome Russian diesel into the U.S., Michael Bernstam and Steven Rosefielde write.
Long Read
Korea and Taiwan Built Economies on AI. One Failed IPO Shows Their Fragility.
Thetwo economies now risk entering a tech version of the “resource curse,” writes William Pesek.
Long Read
Moderna CEO: Vaccine Isn’t a Disappointment
Moderna’s stock tanked Thursday following a data leak for the drugmaker’s cancer-vaccine candidate, which is co-developed with Merck.
3 minute read
The Mooch on His Broken Record, the Midterms, and Some Advice for Trump
Anthony Scaramucci made headlines for being fired after only 11 days as White House press secretary.
Long Read
Want to Be Like Larry Ellison? Borrow Against Your Portfolio.
It’s an increasingly popular approach with investors. Just don’t get carried away.
Long Read
Gen Z Isn’t Abandoning Financial Advisors. But It Is Demanding More.
Gen Z investors are turning out to be hyper-engaged, highly communicative, and more connected to their financial advisors.
4 minute read
Compound Planning’s Alex Farman-Farmaian: Financial Advice for the Mega-IPO Era
After seeing equity owners fail to prepare for IPOs, Alex Farman-Farmaian helped start a wealth management company to do something about it.
Long Read
Check out Barron's Advisor Rankings
Barron's ranks the best advisors, firms, and teams in the country. The goal is to shine a spotlight on the nation's best financial advisors, with an eye toward raising standards in the industry.
Find an Advisor
Are you ready to search for a financial advisor? We'll match you with advisors who can help.
Recently Viewed Tickers
SymbolPriceChange% Chg
U.S. Stock Movers
Includes common stocks, ADRs and REITs listed on NYSE, Nasdaq or NYSE American with a prior day close of $2 a share or higher and volume of at least 50,000
| Company (Ticker) | Change Percent | Price |
|---|---|---|
| ClearOne Inc. (CLRO) | 56.48% | $5.34 |
| VCI Global Ltd. (VCIG) | 33.54% | $4.06 |
| Perion Network Ltd. (PERI) | 31.21% | $11.42 |
| MindForge Inc. (MF) | 27.19% | $10.62 |
| aTyr Pharma Inc. (ATYR) | 22.57% | $6.06 |